未登录

S

Simone Theilade

Steno Diabetes Center Copenhagen

H指数:21

被引数:1,611

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes

糖尿病足并发症的代谢组学风险预测因子：1型糖尿病的纵向观察性研究

diabetes obesity metabolism

IF0

2025-08-120

OA

Debulking Surgery After Muscular Paraffin Oil Injections: Effects on Calcium Homeostasis and Patient Satisfaction

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2024-09-030

OA

Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2024-04-112

OAAI

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes

IF7.5

2023-07-216

OAAI

Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?

CARDIOVASCULAR DIABETOLOGY

IF10.6

2023-06-293

OAAI

Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

CARDIOVASCULAR DIABETOLOGY

IF10.6

2022-07-1814

OAAI

Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-04-1412

OAAI

Treatment options for hypercalcemia after cosmetic oil injections: Lessons from human tissue cultures and a pilot intervention study

IF3.6

2022-01-014

OAAI

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2021-10-1310

OAAI

An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight

DIABETES OBESITY & METABOLISM

IF5.7

2021-02-2331

OAAI

Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

IF16.6

2020-12-156

OAAI

Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes

DIABETIC MEDICINE

IF3.4

2020-11-236

PREAI

Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2020-10-0627

OAAI

Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and Severity

JOURNAL OF BONE AND MINERAL RESEARCH

IF5.9

2020-09-158

OAAI

Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes

IF7.5

2020-07-3147

OAAI

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2019-11-2246

OAAI

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes

SCIENTIFIC REPORTS

IF3.9

2019-11-0858

OAAI

Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study

IF10.2

2019-10-3021

OAAI

Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

IF3.7

2019-09-1418

OAAI

Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes

IF16.6

2019-07-0134

OAAI